|
| 36242804 | Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2022 |
| 33143745 | Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS. | BMC Med | 2020 |
| 30447419 | Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study. | J Neuroimmunol | 2019 |
| 29921915 | DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. | Nat Commun | 2018 |
| 28170401 | Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results. | PLoS One | 2017 |
| 27652346 | Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. | Neurology: Genetics | 2016 |
| 27806057 | Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis. | PLoS One | 2016 |
| 24608124 | Human leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosis. | PLoS ONE | 2014 |
| 24076602 | Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. | Nat Genet | 2013 |
| 22586495 | Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis. | PLoS ONE | 2012 |
| 21742385 | No influence on disease progression of non-HLA susceptibility genes in MS. | Journal of Neuroimmunology | 2011 |
| 21833088 | Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. | Nature | 2011 |
| 20502484 | Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. | Nat Genet | 2010 |
| 20678810 | Two HLA class I genes independently associated with multiple sclerosis. | Journal of Neuroimmunology | 2010 |
| 19888296 | A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. | European Journal of Human Genetics | 2010 |
| 20018638 | HLA-DRB1 and month of birth in multiple sclerosis. | Neurology | 2009 |
| 18176743 | Loss-of-function variants of the filaggrin gene are associated with atopic eczema and associated phenotypes in Swedish families. | Acta Derm Venereol | 2008 |
| 18997785 | Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. | Nat Genet | 2008 |
| 16685656 | Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis. | Am J Hum Genet | 2006 |
| 8624683 | Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. | Brain | 1996 |
| 8610980 | Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells. | Annals of the New York Academy of Sciences | 1996 |
| 7627624 | Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. | | 1995 |
| 9345450 | Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease. | Multiple Sclerosis Journal | 1995 |
| 7537278 | Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis. | Journal of Neuroimmunology | 1995 |
| 7532318 | Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. | Scandinavian Journal of Immunology | 1995 |
| 7542576 | High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood. | Clinical and Experimental Immunology | 1995 |
| 7537280 | Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. | Journal of Neuroimmunology | 1995 |
| 7890425 | Cytokine mRNA profiles in mononuclear cells in acute aseptic meningoencephalitis. | Infection and Immunity | 1995 |
| 8182116 | Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis. | Journal of Neuroimmunology | 1994 |
| 7732782 | Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. | Acta Neurologica Scandinavica, Supplement | 1994 |
| 8149667 | Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. | Clinical and Experimental Immunology | 1994 |
| 8080246 | Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. | Annals of Neurology | 1994 |
| 7507500 | Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta. | Journal of Neuroimmunology | 1994 |
| 7509140 | Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. | Annals of Neurology | 1994 |
| 7513071 | Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. | Neurology | 1994 |
| 7520837 | Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis. | Cellular Immunology | 1994 |